P854: HEXABODY-CD38 INDUCES TROGOCYTOSIS AND EFFECTIVELY INDUCES COMPLEMENT-MEDIATED TUMOR CELL LYSIS AFTER TREATMENT WITH DARATUMUMAB OR ISATUXIMAB IN VITRO

ABSTRACT:

SUBMITTER: Hiemstra I 

PROVIDER: S-EPMC9431333 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature